PNI COVID-19 vaccine

**PNI COVID-19 vaccine** is an investigational **RNA vaccine** program for prevention of **COVID-19** that was disclosed by Precision NanoSystems as a **best-in-class COVID-19 mRNA vaccine candidate** supported by Canadian government funding in 2020. Publicly available information indicates that the program was intended to advance through preclinical development toward clinical testing, leveraging Precision NanoSystems' expertise in lipid nanoparticle and RNA delivery technologies. However, no specific public identifier, active mRNA sequence, named antigen, brand name, clinical trial registration, or later-stage clinical development outcome was clearly disclosed in the available sources, so the product remains only broadly identifiable as a company-sponsored SARS-CoV-2 mRNA vaccine candidate.

Other names

PNI COVID-19 vaccinePrecision NanoSystems COVID-19 vaccine